Sanchez-Valle J, Flores-Rodero M, Costa F, Carbonell-Caballero J, Nunez-Carpintero I, Tabares-Seisdedos R
bioRxiv. 2025; .
PMID: 39896586
PMC: 11785135.
DOI: 10.1101/2025.01.22.634077.
Le J, Sun Y, Deng G, Dian Y, Xie Y, Zeng F
Hum Vaccin Immunother. 2025; 21(1):2458948.
PMID: 39894761
PMC: 11792813.
DOI: 10.1080/21645515.2025.2458948.
Liu Z, Jin K, Xu Z, Xu J, Su X, Li B
BMJ Oncol. 2025; 2(1):e000199.
PMID: 39886491
PMC: 11234999.
DOI: 10.1136/bmjonc-2023-000199.
Tian J, Zhang L, Lin F, He R, Tian W, Yan L
Front Med (Lausanne). 2025; 11:1515263.
PMID: 39867925
PMC: 11759289.
DOI: 10.3389/fmed.2024.1515263.
Zhou J, Li M, Chen Y, Wang S, Wang D, Suo C
Biol Sex Differ. 2024; 15(1):106.
PMID: 39716176
PMC: 11664931.
DOI: 10.1186/s13293-024-00682-4.
Sex differences in patients with Non-Small Cell Lung Cancer harboring driver fusions treated with tyrosine kinase inhibitors: a systematic review.
Leporati R, Auclin E, Morchon D, Ferriol-Galmes M, Laguna J, Gorria T
Ther Adv Med Oncol. 2024; 16:17588359241306940.
PMID: 39697619
PMC: 11653452.
DOI: 10.1177/17588359241306940.
Elucidating Sex-Specific Immune Profiles in a Breast Cancer Model.
Hargrove-Wiley E, Obodo D, Bindeman W, Fingleton B
Int J Mol Sci. 2024; 25(23).
PMID: 39684829
PMC: 11641823.
DOI: 10.3390/ijms252313113.
Sex differences in the pharmacokinetics of anticancer drugs: a systematic review.
Delahousse J, Wagner A, Borchmann S, Adjei A, Haanen J, Burgers F
ESMO Open. 2024; 9(12):104002.
PMID: 39662226
PMC: 11697095.
DOI: 10.1016/j.esmoop.2024.104002.
Ancestral Differences in Anticancer Treatment Efficacy and Their Underlying Genomic and Molecular Alterations.
Luo M, Yang J, Schaffer A, Chen C, Liu Y, Chen Y
Cancer Discov. 2024; 15(3):511-529.
PMID: 39601595
PMC: 11875934.
DOI: 10.1158/2159-8290.CD-24-0827.
Somatic mutational landscape reveals mutational signatures and significantly mutated genes of cancer immunotherapeutic outcome and sex disparities.
Li Y, Wang Q, Gao X, Zheng J, Zhang W, Ren Y
Front Immunol. 2024; 15:1423796.
PMID: 39555056
PMC: 11563811.
DOI: 10.3389/fimmu.2024.1423796.
Insights into sex differences in perioperative outcomes of non-small cell lung cancer patients.
Zheng Q, Zhou J, Zhang Y, Wang T, Wu D, Pu Q
Transl Lung Cancer Res. 2024; 13(10):2549-2560.
PMID: 39507041
PMC: 11535826.
DOI: 10.21037/tlcr-24-336.
The pharmacogenomic and immune landscape of snoRNAs in human cancers.
Wang R, Chen C, Liu Y, Luo M, Yang J, Chen Y
Cancer Lett. 2024; 605:217304.
PMID: 39426663
PMC: 11898246.
DOI: 10.1016/j.canlet.2024.217304.
Facilitating integrative and personalized oncology omics analysis with UCSCXenaShiny.
Li S, Peng Y, Chen M, Zhao Y, Xiong Y, Li J
Commun Biol. 2024; 7(1):1200.
PMID: 39341906
PMC: 11439031.
DOI: 10.1038/s42003-024-06891-2.
Mechanisms of long COVID and the path toward therapeutics.
Peluso M, Deeks S
Cell. 2024; 187(20):5500-5529.
PMID: 39326415
PMC: 11455603.
DOI: 10.1016/j.cell.2024.07.054.
Oligometastatic non-small cell lung cancer: Impact of local and contemporary systemic treatment approaches on clinical outcome.
Wiesweg M, Kuter C, Schnorbach J, Keyl J, Metzenmacher M, Cvetkovic J
Int J Cancer. 2024; 156(4):776-787.
PMID: 39319506
PMC: 11661509.
DOI: 10.1002/ijc.35199.
Triple therapy boosts survival in NSCLC patients with brain metastases: a retrospective cohort study of chemotherapy, ICIs, and antiangiogenic agents.
Yang D, Munai E, Zeng S, Tao D, Yuan Z, Du L
Cancer Immunol Immunother. 2024; 73(11):226.
PMID: 39237636
PMC: 11377371.
DOI: 10.1007/s00262-024-03797-0.
Comparative analysis of adverse event risks in breast cancer patients receiving pembrolizumab combined with paclitaxel paclitaxel monotherapy: insights from the FAERS database.
Li Y, Yang X, Ma L
Front Pharmacol. 2024; 15:1345671.
PMID: 39234109
PMC: 11372242.
DOI: 10.3389/fphar.2024.1345671.
The influence of sex hormones on renal cell carcinoma.
Ladurner M, Lindner A, Rehder P, Tulchiner G
Ther Adv Med Oncol. 2024; 16:17588359241269664.
PMID: 39175990
PMC: 11339752.
DOI: 10.1177/17588359241269664.
SexAnnoDB, a knowledgebase of sex-specific regulations from multi-omics data of human cancers.
Yang M, Feng Y, Liu J, Wang H, Wu S, Zhao W
Biol Sex Differ. 2024; 15(1):64.
PMID: 39175079
PMC: 11342657.
DOI: 10.1186/s13293-024-00638-8.
Association of TP53 Mutation Status and Sex with Clinical Outcome in Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors: A Retrospective Cohort Study.
Choi S, Kim S, Lee S, Seo J, Kang M, Jung E
Cancer Res Treat. 2024; 57(1):70-82.
PMID: 39118525
PMC: 11729308.
DOI: 10.4143/crt.2024.046.